MENU
AKBA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Akebia Therapeutics (AKBA) Ownership - Who owns Akebia Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
400.36M
P/E Ratio
N/A
Total Cash
34.02M
Projected Growth
N/A
Total Debt
48.58M
Revenue
169.88M
Risk (Beta)
0.31
Dividend Yield
N/A
Total Cash/Share
0.16
Total Debt/Equity
N/A
Revenue/Share
0.83 USD as % of share price
Fundamentals
AKBA
Capitalization
400M
P/E Ratio
N/A
Risk (Beta)
0.31
Dividend Yield
N/A
Total Cash
34M
Total Cash/Share
0.16
Total Debt
48.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.83%
Revenue
170M
ROE
N/A
Book Value
-50.4M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
1.52
Current Revenue Per Employee
224119.77
Dividends Per Share - Security
N/A
EBITDA
4.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
62.16
Revenue To Assets
-20.80
Shares Held By Institutions
125M
Shares Outstanding - Current
218M
Total Liabilities
258M
Total Volume MTD
N/A
Value
-1
Gain YTD
47.581
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs for the treatment of anemia and vascular diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com